Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
$MLLCF Q2 '26 Earnings Results & Recap For the full year 2026, Molecular Partners maintains its previously reported forecast with total operating expenses of CHF 45-55 million expected, including approximately CHF 6 million of non-cash effective costs.

Price since post

Full Details

Advertisement|Remove ads.